This connection between heart rate variability and fatty liver disease was found in a study with many participants followed over time

Scientific Claim

The association between low heart rate variability and non-alcoholic fatty liver disease development was observed in a large cohort study

Original Statement

“Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease”

From study:Author Correction: Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease

Evidence Quality Assessment

Claim Status

appropriately stated

Study Design Support

Design supports claim

Appropriate Language Strength

association

Can only show association/correlation

Assessment Explanation

The claim accurately describes the study design as a cohort study without overstatement.

Evidence from Studies

Supporting (1)

Author Correction: Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease

Cannot Determine

Human

2022 Dec 9

Contradicting (0)

No contradicting evidence found

Source Study

Author Correction: Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease

Score: 20

DOI: 10.1038/s41598-022-25977-7

Similar Assertions

Fatty liver disease is more common in people whose hearts don't change rate as much

96%

People who don't already have liver problems but have lower heart rate variability are more likely to develop fatty liver disease later

95%

People whose hearts don't change rate as much are more likely to develop fatty liver disease than people whose hearts change rate more

92%

People with lower heart rate variability (a measure of how much heart rate changes) from very short heart recordings are more likely to develop fatty liver disease later on

90%

A very quick heart rate measurement might help doctors identify people who are more likely to develop fatty liver disease in the future

86%